Over the past seven years, there has been an explosion in acquisition and investment activity in the dermatology market.
From the perspective of a buyer in this marketplace, they value practices that have repeatable customers and revenue. A buyer will also focus on practice attributes, such as attrition rate of patients, backlog of patient appointments, history of procedures per patient and frequency that the average patient visits the facility.
“Many dermatology practices are innovating to increase their top-line opportunities,” says A&M Managing Director Andrew Henoch in a recent report in Practical Dermatology.
A Closer Look at the Life Sciences Industry: 2025 Life Sciences Report
December 18, 2025
A&M is pleased to present a copy of our 2025 Health of the Life Sciences Industry Report.
Where AI Meets Financial Impact
December 8, 2025
CFOs are uniquely positioned to lead the charge on value creation, leveraging emerging technologies to unlock deeper insights and optimise business decisions. This article explores the transformative potential of AI for financial impact and strategic decision-making.
M&A commentary: Surge in value of deals
December 3, 2025
The ONS data shows M&A activity Q3 remained low, however, since September we’ve seen an uptick. The market seems to have shrugged off market disruption and restarted in earnest. Mike Trenouth provides comments on the latest data release.
A year of recalibration and resilience
December 2, 2025
Private Equity funds have had to be resilient through rising geopolitical tensions, the shock form US tariffs and several years of subdued deal flow and limited exits. But, as 2025 comes to a close, European private equity is showing signs of stability.